Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard Post History

by Donein25


V.TLT

RE:Interpretation of latest NR

I think you are reading too much into this PR. The #s quoted by Dr. Mandel...

February 2, 2023

V.TLT

RE:Moving to NASDAQ once FDA designation is granted

SF  Are you suggesting that our stock price will appreciate organically...

February 1, 2023

V.TLT

Volume

I'm seeing 508k here in US. Anyone else see that?

January 11, 2023

V.TLT

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:January 9th warrants

Fab. You are correct. This is a touchy subject for some, but the reality is...

January 7, 2023

V.TLT

RE:RE:RE:RE:RE:RE:RE:9 more sites

Infinity, your thoughts on first line treatment caught my attenetion. The...

January 4, 2023

V.TLT

RE:Vaccine

Nothings coming on the vaccine. They are developing a laser system for it...

December 16, 2022

V.TLT

RE:RE:RE:CG Oncology NMIBC data

Yes. This is how we should view our potential value. 

December 1, 2022

V.TLT

RE:RE:CG Oncology NMIBC data

Agreed. Their monotherapy #s are not that impressive, but the combo #s are...

December 1, 2022

V.TLT

RE:RE:CG Oncology NMIBC data

Good to hear. Thaks ScienceFirst.

December 1, 2022

V.TLT

CG Oncology NMIBC data

ScieneFirst. What are we to make of their CG0070? They have released...

December 1, 2022

V.TLT

RE:RE:BioTuesdays by Kilmer Lucas

Agreed. His 2026 timeline also doesn't appear to take into account...

December 1, 2022

V.TLT

RE:The Dawg's stock analysis

Nice analysis Dawg. Agree on BTD and RDW catalysts, then maybe a JV around...

November 30, 2022

V.TLT

Options

These options can also be used to attract new MSAB members for new...

November 21, 2022

Prev 1 2 3 4 5 6

Featured Company